DOD Biotech PCL (BKK:DOD-R) Interest Expense : ฿-3.7 Mil (TTM As of Mar. 2025)

View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. DOD Biotech PCL's interest expense for the three months ended in Mar. 2025 was ฿ -0.5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was ฿-3.7 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. DOD Biotech PCL's Operating Income for the three months ended in Mar. 2025 was ฿ 17.6 Mil. DOD Biotech PCL's Interest Expense for the three months ended in Mar. 2025 was ฿ -0.5 Mil. DOD Biotech PCL's Interest Coverage for the quarter that ended in Mar. 2025 was 36.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

DOD Biotech PCL Interest Expense Historical Data

The historical data trend for DOD Biotech PCL's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Interest Expense Chart

DOD Biotech PCL Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-6.85

-6.72

-7.10

-5.31

-3.73

DOD Biotech PCL Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Interest Expense	Get a 7-Day Free Trial															-1.18	-1.78	-0.83	-0.64	-0.49

DOD Biotech PCL Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-3.7 Mil.

DOD Biotech PCL (BKK:DOD-R) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

DOD Biotech PCL's Interest Expense for the three months ended in Mar. 2025 was ฿-0.5 Mil. Its Operating Income for the three months ended in Mar. 2025 was ฿17.6 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was ฿0.1 Mil.

DOD Biotech PCL's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2025 )	/	Interest Expense (Q: Mar. 2025 )
	=	-1	*	17.633	/	-0.488
	=	36.13

The higher the ratio, the stronger the company's financial strength is.

DOD Biotech PCL Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD-R) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

DOD:Thailand

Address

No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000

Website

https://www.dodbiotech.com

DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines